1. Introduction {#s0005}
===============

Many enzymes are concerned with energy homeostasis among them 5 AMP activated protein kinase (EC 2.7.11.31) that regulates the energy homeostasis inside the cell ([@b0320]). The enzyme has been confirmed to be expressed in liver ([@b0095]), and muscles ([@b0070]). Activation of the enzyme leads to activation of fatty acids oxidations in muscles and liver, ketogenesis, glucose uptake by the cells and inhibition of cholesterol synthesis, lipogenesis, triglycerides synthesis and modulation of insulin secretion by beta cells of pancreas ([@b0320]). Several studies which have been used agents for controlling of Diabetes Mellitus (DM) pointed AMPK as target ([@b0100], [@b0185], [@b0335]). DM as a chronic metabolic disorder is attractive for many researchers. There is a daily continuous seeking for a modulator or preventer for DM, however the success of the modulator depends on its target inside the body and its relevance to the disorder ([@b0265]). Natural agents' especially medicinal plants now constitute the major targets used for controlling of DM ([@b0225]). *Panax ginseng* is a medicinal plant contributed for the controlling of many disorders ([@b0260]), in the same line, its pharmacological action have been demonstrated in disorders such as cancer including; breast, lung, liver, colon and skin cancer ([@b0210]), cardiovascular diseases ([@b0365]), acute menopausal symptoms ([@b0125]), acute pancreatitis ([@b0190]), it has been used for stimulating immune activity ([@b0120], [@b0350]), as a neuro-protective agent ([@b0205]), and for its antioxidant activities ([@b0280]), anti stress ([@b0310]) and anti-aging ([@b0015]) activities. Ginseng now is one of the most famous natural agents used in controlling the metabolic syndromes such as DM and its complications ([@b0065], [@b0135], [@b0315], [@b0340]). Recently, it has been demonstrated that ginseng can improves the glucose intake, attenuates insulin resistance and reduce fat mass in high fat diet-obesity mice ([@b0060]). The matter which gives us the impetus to study the effectiveness of Panax ginseng on enzymes and proteins related to DM. We considered AMPK as a target in the present study. Its mRNA expression levels were measured in the all experimental animals, beside the expression levels of glucose transporter-2 (GLUT-2), Insulin receptor A (IRA) and activities of Glucokinase (GK), Glycogen synthase (GS) in livers of experimental groups. Blood glucose, insulin, total Cholesterol (TC), triacyl-glycerol (TAG), HDL-cholesterol (HDL-c), LDL-cholesterol levels were also determined.

2. Material and methods {#s0010}
=======================

2.1. Animals selection and grouping {#s0015}
-----------------------------------

Forty male albino rats 6 month of age and weighing 120 ± 20 g were obtained from the animal house of Zagazig University, Egypt. The animal were housed in individual suspended stainless steel cages at 22 ± 2 °C with a 12 h light/dark cycle and allowed to acclimatize for period of 7 days before beginning the experiment. Rats were divided randomly into 4 groups (n = 10) and were allowed free access to food and water. Rats were divided randomly into 4 groups. (n = 10) in each. Group I served as non-treated control group, group II received daily dose of ginseng 200 mg/kg Bwt for constitutive 30 days, group III STZ-induced diabetic rats did not receive any type of treatment, group IV STZ-induced diabetic rats received 200 mg/kg Bwt of ginseng for constitutive 30 days.

2.2. Chemicals {#s0020}
--------------

Streptozotocin (STZ) (Sigma-Aldrich Co. St. Louis, Missouri, USA). Root powder of Korean ginseng (*Panax ginseng* C.A. Meyer).

2.3. Ethical statement {#s0025}
----------------------

All procedures of the current experiment have been approved by the Ethical Committee of the Faculty of Vet. Med. Zagazig University Egypt.

2.4. Induction of experimental diabetes mellitus {#s0030}
------------------------------------------------

Diabetes mellitus was induced by a single intra-peritoneal injection of 100 mg/kg B.wt. of a freshly prepared Streptozotocin powder "STZ" (Sigma-Aldrich Co. St. Louis, Missouri, USA) dissolved in 0.01 M cold sodium citrate buffer (pH 4.5) immediately before use. The rats with STZ were given 5% W/V glucose solution next 24 h to prevent the hypoglycemia. After 72 h rats with fasting blood glucose more than 250 mg/dL had been selected as diabetic rats ([@b0005]).

2.5. Sampling protocol {#s0035}
----------------------

After 12 h fasting, the blood samples were collected from median canthus of eye and the sera were separated by centrifugation and stored at −20 °C for biochemical determinations. Liver tissues were collected and divided in to two parts. The first part was used to prepare a tissue homogenate for biochemical measurements of enzymes activities and the other part collected on liquid nitrogen, preserved at −80 °C until the extraction of RNA and was used for gene expression investigation.

2.6. Biochemical determinations {#s0040}
-------------------------------

The blood glucose concentrations were determined using glucose oxidase method and the kits provided by SPINREACT (Sant Esteva de Bas, Girona, Spain). The insulin levels in serum were estimated using IMMULITE Insulin kits (Catalog Number: LKIN1, Avenue, Silver Spring, MD 20993) following manufacture instructions ([@b0045]). Serum total cholesterol ([@b0250]), triacyl-glycerols ([@b0075]), HDL - cholesterol ([@b0200]), and LDL-cholesterol ([@b0080]) were determined in the sera of all experimental animals. The activities of hepatic GK ([@b0240]) and GS ([@b0020]) were determined in the liver tissue homogenates of all experimental rats.

2.7. Molecular biological determinations {#s0045}
----------------------------------------

### 2.7.1. RNA extraction and cDNA synthesis {#s0050}

Total RNA was extracted from liver tissue using RNeasy Mini Kit (Qiagen, Cat. No. 74104) and following the manufacturer instructions. The amount of extracted RNA was quantified and qualified by NanoDrop® ND-1000 Spectrophotometer, NanoDrop Technologies, Wilmington, Delaware USA. The first strand cDNA was synthesized by using RevertAidTM H Minus (Fermentas, life science, Pittsburgh, PA, USA).

### 2.7.2. Primers for experimental genes {#s0055}

The primers pairs were designed according to the previously published data as following AMPKα1 (ID: 65248); forward, 5′-ATCCGCAGAGAGATCCAGAA-3′ and reverse 5′-CGTCGACTCTCCTTTTCGTC-3′ ([@b0215]), IRA (ID: 24954); forward, 5′-TTCATTCAGGAAGACCTTCGA-3′ and reverse, 5′-AGGCCAGAGATGACA AGTGAC-3′, GLUT-2 (ID: 25351); forward, 5′-TTAGCAACTGGGTCTGCAAT-3′, and reverse 5′-TCTCTGAAGACGCCAGGA AT-3′ ([@b0005]), and ß-actin (ID: 81822); forward, 5′- AGCCATGTACGTAGCCAT -3′ and reverse 5- CTCTCAGCTGTGGTGGTGAA -3′ ([@b0010]).

### 2.7.3. Real time PCR {#s0060}

One μL of cDNA was mixed with 12.5 μL of 2x SYBR® Green PCR mix from BioRad, 5.5 μL of autoclaved water, and 0.5 μL (10 pmol/μL) of each forward and reverse primer for the measured genes. The house keeping gene β-actin was used as a control for normalization. Fold change was calculated using the (2^−ΔΔct^) method to quantitate mRNA levels, according to [@b0195].

2.8. Statistical analysis {#s0065}
-------------------------

The obtained data was analyzed by using the statistical package for social science (SPSS, 18.0 software, 2011). Differences among groups was evaluated using one way ANOVA. Results were expressed as mean ± SE. P values less than 0.05 were considered to be significant.

3. Results {#s0070}
==========

3.1. Fasting blood glucose (mg/dL) and serum insulin (µIU/mL) levels. {#s0075}
---------------------------------------------------------------------

There were a significant decrease in the blood glucose levels in diabetic rats received ginseng as compared to diabetic non-treated rats. The insulin levels were significantly increased in diabetic rats received ginseng also if compared with diabetic non-treated groups at P \< 0.05 ([Table 1](#t0005){ref-type="table"}).Table 1Fasting blood glucose and serum insulin levels in experimental rats.GroupsGlucose (mg/dL)Insulin (µIU/mL)Control80.5 ± 14.3^c^13.8 ± 0.51^c^Normal + ginseng78.3 ± 24^c^13.2 ± 0.38^c^Diabetic298 ± 28.17^a^7.9 ± 0.11^a^Diabetic + ginseng167.9 ± 3.4^b^11.2 ± 0.23^b^[^1]

3.2. Glucokinase (U/gm tissue) and glycogen synthase (mU/mg protein) activities in liver tissues. {#s0080}
-------------------------------------------------------------------------------------------------

The activities of glucokinase and glycogen synthase were significantly increased in diabetic rats received ginseng if compared with diabetic non-treated rats at p \< 0.05 ([Table 2](#t0010){ref-type="table"}).Table 2Liver glucokinase and glycogen synthase activities in experimental rats.GroupsGlucokinase (U/g liver tissue)Glycogen synthase (mU/mg protein)Control1.21 ± 0.02^a^3.7 ± 0.08^a^Normal + ginseng1.43 ± 24^a^3.5 ± 0.38^a^Diabetic0.16 ± 0.008^b^1.98 ± 0.1^c^Diabetic + ginseng1.03 ± 0.05^a^2.7 ± 0.22^b^[^2]

3.3. Serum lipid profiles (mg/dL). {#s0085}
----------------------------------

There were a significant decrease in the concentrations of total cholesterol, tri-acylglycerols and LDL-cholesterol (mg/dL) in diabetic rats received ginseng if compared with the diabetic non-treated rats. The level of HDL-cholesterol was significantly decreased in diabetic rats received ginseng when compared with diabetic non-treated rats at P \< 0.05 ([Table 3](#t0015){ref-type="table"}).Table 3Serum lipids profile levels in experimental rats.GroupsTotal cholesterol (mg/dL)Triglycerides (mg/dL)HDL-cholesterol (mg/dL)LDL- cholesterol (mg/dL)Control87.2 ± 1.35^c^83.4 ± 2.51^b^46.18 ± 2.93^b^23.34 ± 1.59^c^Normal + ginseng81.9 ± 1.51^c^82.2 ± 3.25^b^48.87 ± 1.52^b^15.9 ± 1.44^d^Diabetic171.8 ± 2.1^a^119 ± 0.11^a^38.3 ± 2.02^a^99.5 ± 2.92^a^Diabetic + ginseng111.3 ± 2.83^b^85 ± 1.92^b^48.1 ± 1.56^b^45.2 ± 2.17^b^[^3]

3.4. mRNA expression levels of AMPK, IRA, and GLUT2. {#s0090}
----------------------------------------------------

The mRNA expression levels of AMPK, IRA and GLUT2 proteins was increased in the diabetic rats received ginseng if compared with diabetic non-treated rats at P \< 0.05 ([Table 4](#t0020){ref-type="table"}).Table 4mRNA expression levels of examined proteins in experimental rats.GroupsAMPKIRAGLUT2Control1.05 ± 0.20^a^1.07 ± 0.21^a^1.11 ± 0.28^a^Normal + ginseng1.02 ± 0.28^a^1.03 ± 14^a^1.05 ± 0.18^a^Diabetic0.45 ± 0.26^b^0.36 ± 0.08^b^0.48 ± 0.1^b^Diabetic + ginseng0.96 ± 0.11^a^0.87 ± 0.05^a^0.91 ± 0.22^a^[^4]

4. Discussion {#s0095}
=============

The present work studied the molecular and biochemical effects of Panax ginseng on some enzymes and proteins related to glucose metabolism in diabetic rats. The effect on AMPK mRNA expression levels was estimated. The mRNA of AMPK showed the lowest expression level among diabetic rats (0.45 ± 0.26), while its expression level was modulated and increased in all rats received ginseng, normal (1.02 ± 0.28) and diabetic (0.96 ± 0.11) respectively. The results explained the great association between AMPK action and the incidence of diabetes mellitus the matter which making AMPK a popular target when study DM. recently it has been demonstrated that activation of AMPK could promote the glucose uptake by the cells ([@b0220]) and the ability of ginseng to induce an up-regulation of AMPK expression in diabetic rats lead to decline the blood glucose in experimental rats received ginseng 1.02 and 1.78 times in normal and diabetic rats respectively. The same observations have been obtained in human by [@b0050], ginseng has induced lowering in blood glucose of diabetic patients specially those of fasting blood glucose (FBG) of 110 mg/dL or more ([@b0050]). We also reported the effect of ginseng on serum insulin levels. Insulin level was increased by 1.42 times in diabetic rats received ginseng when compared with non treated rats. In the same line, other studies reported the hypoglycemic effect of ginseng in diabetic/obese models ([@b0135], [@b0160], [@b0300]), it has been reported to induce an increase in serum insulin levels ([@b0315]), and improved the insulin tolerance ([@b0065]) in diabetic mice. There is a great prove now that the activation of AMPK can lead to increasing insulin secretion and improve its tolerance ([@b0110], [@b0325], [@b0360]). We can indicate the effect of ginseng to reduce serum blood glucose and increase serum insulin levels to its ability to induce up-regulation of AMPK expression in diabetic rats. Coming with this up-regulation there was a significant up-regulation of IRA and GLUT2 ([Fig. 1](#f0005){ref-type="fig"}). Ginseng significantly increased the expression of IRA and GLUT2 0.87 and 0.91 fold respectively in diabetic rats received ginseng when compared to diabetic non-treated rats 0.36 and 0.48 fold respectively. In a similar study the effect of ginseng on insulin receptor has been reported to induce high expression in insulin receptor B (IRB) and insulin receptor substrate-1 (IRS) ([@b0060]). Another study reported the ability of ginseng to induce up-regulation of insulin receptors in muscles of metabolic syndrome rats ([@b0130]). Our data regarding mRNA expression of IRs come in accordance with the study of ([@b0040]) which reported the increase IR mRNA expression in old-aged ob/ob mice received *Panax ginseng* for 16 weeks. In this direction, our data proved the ability of ginseng to improve insulin sensitivity in diabetic rats. There were many studies that have demonstrated the effect of ginseng on GLUTs, it have been reported that ginseng induced translocation of GLUT4 ([@b0305], [@b0235]), up-regulation of GLUT4 in muscles of diabetic rats ([@b0150], [@b0115]), high expression levels of GLUT1 and GLUT4 in myotubes of diabetic rats ([@b0270]), increase the expression of GLUT1 and GLUT4 in livers of diabetic mice ([@b0105], [@b0330]), , and up-regulation of GLUT4 in adipose tissue of diabetic rats ([@b0140]). Regarding GLUT2 mRNA expression levels our data come in the same line of ([@b0115]) which demonstrated the high expression levels of hepatic GLUT2 hand by hand with high phosphorylation of AMPK in diabetic mice received ginseng for 4 weeks. Similar data have been come with the same line of our observations regarding high expression levels of GLUT2 in different cell lines/tissues of diabetic models received ginseng ([@b0230], [@b0085], [@b0180]). In general, the ability of ginseng to increase the expression levels of GLUTs and especially GLUT2 explained its ability to increase the uptake of glucose by insulin targeted-cells especially liver cells. The matter which translated to lower blood glucose in diabetic models received ginseng. Also we showed that *Panax ginseng* induced a significant increase in activities of hepatic GK (6.4 times) and GS (1.36 times) of diabetic rats received ginseng for 30 days if compared with non-treated rats. Their activities also non significantly increased in non-diabetic rats received ginseng when compared with control. It well-known that hepatic GK activity and expression are decreased in DM ([@b0295]), in the same way, we observed the lowest activity of GK in diabetic non-treated rats. It was also known that glycogen storage is impaired in livers of diabetic models due to impairment of GS ([@b0255]) the matter which leads to hyperglycemia. Many targets which have been used to lower blood glucose in diabetic models targeted the activation of the two enzymes. The activation of AMPK has lead to an increase in GK and GS activities ([@b0030])). In our study, ginseng activated both GK and GS in diabetic rats. Ginseng has to increase GK expression in adipocytes ([@b0155]) and induced the expression of GK in pancreatic cells ([@b0245]), in the same line, ginseng have to increase hepatic or muscles glycogen deposition ([@b0330], [@b0345]) through inhibition of Glycogen synthase kinase (GSK) in hepatocytes ([@b0130], [@b0355], [@b0285]). Others conclude that ginseng have to suppress the expression of GS ([@b0270]). Although, there were a lot of data about the molecular effect of ginseng on GK and GS expressions, to the best of our knowledge, we are the first record for the assessment of direct effect of *Panax ginseng* on the enzymatic activities of hepatic GK and GS. On the contrary of our data, authors reported the inhibitory effect of *Panax ginseng* on ovarian Hexokinase ([@b0175]), while the study of ([@b0055]) on hepatic Hexokinase agreed with us. The ability of ginseng to activate both GK and GS activities indicates how it reduces blood glucose in diabetic rats. It does so through activating both glucose oxidation (glycolysis) and increase glycogen deposition (glycogenesis) through AMPK activation pathway ([Fig. 2](#f0010){ref-type="fig"}). Also lipids profiles tended to be reduced in diabetic rats received ginseng. Usually DM is characterized by an impairment of lipids metabolism ([@b0025]). The progress of DM without glycemic control by the way will induce distorted blood lipids profile (dyslipidemia) ([@b0170]). We tested the ability of *Panax ginseng* to correct this impairment. In the present study, ginseng increased the levels of HDL-c and decreased TC, TGs, and LDL-c. Our results come in accordance with the results obtained from studying the effect of different types of ginseng on dyslipidemic models. It has been reported that ginseng can reduce blood TGs ([@b0160]), plasma TGs and cholesterol, LDL-c ([@b0040], [@b0090], [@b0145], [@b0165], [@b0035], [@b0115], [@b0290]). Although, others found that there was no significant change in HDL-c levels between treated and non-treated models ([@b0090]), we reported an increase in serum HDL-c in diabetic rats received ginseng. It has been reported that activation of AMPK will targeted for all lipid metabolism processes leading to oxidation ([@b0275]) and so will reduce blood lipids. We relate the activity of ginseng to lower high lipid levels in diabetic rats to its ability to activate AMPK. The overall observation indicated that *Panax ginseng* can modulates the dyslipidemias originated from DM.Fig. 1Relationship between AMPK expression and IRA and GLUT2 expression in hepatocytes.Fig. 2Correlation between AMPK expression and GK and GS activities in diabetic rats.

5. Conclusion {#s0100}
=============

In conclusion, the study pointed to the ability of *Panax ginseng* to reduce blood glucose in diabetic rats through activation of AMPK pathways, increase insulin secretion and tolerance, increase glucose uptake and oxidation, and increase glycogen deposition in liver cells.

6. Conflicts of interest {#s0105}
========================

The authors declare no conflict of interest.

Peer review under responsibility of King Saud University.

[^1]: Means carrying different superscripts are significant at P \< 0.05.

[^2]: Means carrying different superscripts are significant at P \< 0.05.

[^3]: Means carrying different superscripts are significant at P \< 0.05.

[^4]: Means carrying different superscripts are significant at P \< 0.05.
